Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

Novartis Pharmaceuticals · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
spondylitis, ankylosing, ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 837021
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.